In 2023, the French Society of Hospital Hygiene published a position paper outlining infection control measures for suspected or confirmed cases of mpox in healthcare settings [1]. A comprehensive literature review on mpox clade IIb transmission recommended contact precautions and the use of surgical masks. Airborne transmission has not been confirmed; therefore, the use of respirators such as KN95 or FFP2 was deemed an unnecessary burden, resulting in added costs and discomfort for healthcare workers (HCWs) [1].